--- title: "Buybacks and M&A Accelerate as HK Small-Caps Navigate Earnings Pressure" type: "News" locale: "en" url: "https://longbridge.com/en/news/296206972.md" description: "Faced with shrinking profits, HK-listed mid-and-small caps like CMS, JF Wealth, and CardioFlow are leaning heavily into share buybacks, dividends, and strategic investments to anchor valuations and deploy capital effectively." datetime: "2026-08-18T09:43:45.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296206972.md) - [en](https://longbridge.com/en/news/296206972.md) - [zh-HK](https://longbridge.com/zh-HK/news/296206972.md) generator: "portal-rs" --- # Buybacks and M&A Accelerate as HK Small-Caps Navigate Earnings Pressure Capital allocation is doing the heavy lifting for a diverse group of Hong Kong equities this quarter, as management teams turn to buybacks, dividends, and M&A to offset significant pressure on the top and bottom lines. The numbers reflect a clear pivot toward defensive financial engineering. Cash flow conversion is under the microscope for CMS (1681.HK). With trailing twelve-month free cash flow at just RMB 126 million compared to RMB 1.08 billion in statutory profit as of May 2026, the pharmaceutical firm rolled out a HKD 200 million share buyback program. Simultaneously, it deployed RMB 191.4 million into Shanghai Huamao Pharma, balancing shareholder returns with strategic M&A. JF Wealth (9636.HK) and MicroPort CardioFlow (2172.HK) are executing similar defensive maneuvers. JF Wealth aggressively bought back shares worth HKD 7.5 million in late July, acting just before warning that H1 2026 adjusted net income would plummet to between RMB 107 million and RMB 117 million, down from RMB 912.5 million a year earlier. CardioFlow complemented its own buyback with a final dividend of HKD 0.09 per share. When earnings falter, liquidity events become the primary metric for investors. Structural shifts are also accelerating in traditional sectors. ZJLD (1022.HK) is navigating a steep contraction, with 2025 full-year revenue and net profit tumbling 48% and 59%, respectively. The departure of its executive director adds to the uncertainty ahead of its H1 2026 print. In materials, Xinjiang Xinxin Mining (6979.HK) projects H1 2026 revenue of RMB 1.26 billion and recently signed a key merger agreement while pushing forward with its A-share listing process. Meanwhile, Okura Holdings (1655.HK) is diversifying away from its core Japanese pachinko operations, funneling USD 4.08 million into SpaceX via a fund investment. For yield-seeking capital, the Global X USD Money Market ETF (3833.HK) remains a primary vehicle for capturing prevailing dollar rates. In the industrials and real estate space, Heng Hup (3137.HK) maintains its scrap metal operations, while Guorui Health (1891.HK) and broader real estate peers (2329.HK) continue to face structural headwinds, making balance sheet preservation the overriding priority. ### Related Stocks - [01681.HK](https://longbridge.com/en/quote/01681.HK.md) - [02172.HK](https://longbridge.com/en/quote/02172.HK.md) - [09636.HK](https://longbridge.com/en/quote/09636.HK.md) - [01655.HK](https://longbridge.com/en/quote/01655.HK.md) - [01022.HK](https://longbridge.com/en/quote/01022.HK.md) - [06979.HK](https://longbridge.com/en/quote/06979.HK.md) - [03833.HK](https://longbridge.com/en/quote/03833.HK.md) - [01891.HK](https://longbridge.com/en/quote/01891.HK.md) - [02329.HK](https://longbridge.com/en/quote/02329.HK.md) ## Related News & Research - [ZJLD Group, Inc. (6979) Gets a Buy from Orient Securities](https://longbridge.com/en/news/296693352.md) - [MicroPort NeuroTech Artemis Dream intracranial rapamycin stent enters NMPA innovative device green channel](https://longbridge.com/en/news/294276997.md) - [Feiyu Technology held shareholder meeting, approved game business cooperation framework agreement](https://longbridge.com/en/news/290953408.md) - [MicroPort NeuroScientific files HKEX next-day return disclosing share buyback at HKD 10.61-10.82](https://longbridge.com/en/news/290956282.md) - [Glory Health Industry holds annual shareholder meeting](https://longbridge.com/en/news/291257277.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**